United States Anaphylaxis Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Top Companies Analysis
Buy NowUnited States Anaphylaxis Market Outlook
Anaphylaxis is a severe and potentially fatal allergic reaction. It is a life-threatening reaction with respiratory, cardiovascular, cutaneous, or gastrointestinal manifestations. The bulk habitual anaphylactic reaction is caused by foods, insect stings, medications and latex. People with hypersensitive to things in their environment, their immune responses overreact to an antigen by discharging chemicals that cause allergy reaction. Anaphylaxis food reaction could be vital and cause death if the prior management not taken. According to Renub Research, United States Anaphylaxis Market was 5.3 Billion in 2027.
As per the analysis, in the United States, due to anaphylaxis reaction to foods say Eggs, Milk Products, Crustaceans, Fish, Food Additives, Peanuts, Tree nuts/seeds, the death rate frequency increases with every passing year. However, this leads to an increment in the number of patients. Approximately 1,500 deaths in the United States happen every year due to anaphylaxis. From 2009 to 2016, the percentage of claims due to food allergy diagnoses was more vital than any other state’s medical claims. Besides, North Carolina State has the highest rate in 2016 compared to the low percent in 2009. The United States Anaphylaxis Market is expected to grow with a double-digit CAGR of 11.98% during 2020-2027.
The food allergy with the highest average cost and service per patient in 2016 was due to milk products. The United States government authorities and bodies were regularly planning and giving awareness tips. Treatment of anaphylaxis is primarily related to Office or O.P. Services. Patients in the United States consider outpatient emergencies for primary diagnosis and symptoms management. In the United States, Anaphylactic Allergens are more in rural areas as compare to Urban.
The factors driving the United States Anaphylaxis Market are the surge in Allergic Reactions, International Trade & Commerce of Food Materials. However, there are few challenges like a Lack of Awareness & Food Control Infrastructure and Food Control Authorities for this market. As per this research study, United States Anaphylaxis Market was worth US$ 2.4 Billion in 2020.
Deals in Companies
- Mérieux Nutri Sciences expands capabilities in environmental analyses with C.P.G. Lab in Italy
- Eurofins acquires L.A.B. Solution, thereby reinforcing its footprint in the Textile and Leather industries.
- Food Label Regulations in the United States that all packaged foods regulated by F.D.A. under the FD&C Act that are labelled on or after 1 January 2006 must obey food allergen labelling requirements.
This is a must purchase report to get the full picture of the United States Anaphylaxis Market. The report shows that the prevalence of anaphylaxis in the United States' general population is the least of the people; however, growing probably higher.
Renub Research studied the “United States Anaphylaxis Market, Food Reaction Testing by Food Sources (Peanuts, Tree nuts/seeds, Eggs, Milk Products, Crustaceans, Fish, Food Additives, Fruits/Vegetables and Others specific foods) Treatment & Services (Immunology Services, Allergen Testing, Venipunctures, Office or O.P. Services New Patient, Ingestion Challenge Testing, Drugs Administered Other than Oral, Office or O.P. Services Established Patient, Therapeutic, Prophylactic, and Dx Injection/Infusions, Chemistry Tests, E.D. New or Estab Patients, Office or Other O.P. Consults, Pulmonary Diagnostic Testing and Therapies, Inpatient Visits, All Others) Anaphylaxis reaction to peanuts, crustaceans by Age group (0-3 years to Over 60 years), (Urban & Rural) End Users (Laboratory, Emergency Room, Inpatients, Outpatients, Office, Others)” provides current trends of the United States Anaphylaxis Industry.
Market & Patient Numbers of United States Anaphylaxis Food Reaction has been covered from two viewpoints:
• Testing Market
• Diagnose Patient Numbers
Treatments & Services – Market breakup from 14 Viewpoints
1. Immunology Services
2. Allergen Testing
3. Venipunctures
4. Office or O.P. Services New Patient
5. Ingestion Challenge Testing
6. Drugs Administered Other Than Oral
7. Office or O.P. Services Established Patient
8. Therapeutic, Prophylactic, and Dx Injection/Infusions
9. Chemistry Tests
10. E.D. New or Estab Patients
11. Office or Other O.P. Consults
12. Pulmonary Diagnostic Testing and Therapies
13. Inpatient Visits
14. All Others
Food Sources – Market breakup from 9 Viewpoints
1. Peanuts
2. Tree nuts/seeds
3. Eggs
4. Milk Products
5. Crustaceans
6. Fish
7. Food Additives
8. Fruits/Vegetables
9. Other Specific Foods
Segment – Patient Numbers in 9 Age Groups
1. Peanuts
2. Crustaceans
3. Food Additives
Age Group – Patients Diagnose Numbers
1. Age Groups 0 to 3
2. Age Groups 4 to 5
3. Age Groups 6 to 10
4. Age Groups 11 to 18
5. Age Groups 19 to 30
6. Age Groups 31 to 40
7. Age Groups 41 to 50
8. Age Groups 51 to 60
9. Over 60
Rural & Urban – Market & Patient Numbers from 2 Viewpoints
1. Rural Market & Patient Numbers
2. Urban Market & Patient Numbers
End Users – Market breakup from 6 Viewpoints
1. Laboratory
2. Emergency Room
3. Inpatient
4. Out Patient
5. Food Office
6. All Others